CAS 1489389-18-5

CCT245737

CAS: 1489389-18-5

Formel: C₁₆H₁₆F₃N₇O

Reinheit: %

Farbe und Form: Solid

Molekulargewicht: 379.3397

Ref: IN-DA00ABR8

CCT245737

CAS: 1489389-18-5

CCT245737

Formel: C₁₆H₁₆F₃N₇O

Reinheit: ≥95%

Molekulargewicht: 379.34

Ref: 54-BUP12330

CCT245737

CAS: 1489389-18-5

CCT245737 is an orally active, selective Chk1 inhibitor, and is >1,000-fold selective over CHK2 and CDK1.Cost-effective and quality-assured.

Formel: C₁₆H₁₆F₃N₇O

Reinheit: 98.28% - 99.93%

Farbe und Form: Solid

Molekulargewicht: 379.34

Ref: TM-T7080

CCT245737

CAS: 1489389-18-5

(R)-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile

Formel: C₁₆H₁₆F₃N₇O

Reinheit: 97+%

Molekulargewicht: 379.34

Ref: IN-DG759805

CCT245737

CAS: 1489389-18-5

CCT245737 is a novel compound that has shown antitumor activity in colorectal adenocarcinoma cells. The compound induces caspase-independent cell death by activating the death protein. CCT245737 also exhibits chemoresistance and kinase selectivity, which makes it an attractive candidate for the treatment of cancer.

Formel: C₁₆H₁₆F₃N₇O

Reinheit: Min. 95%

Molekulargewicht: 379.34 g/mol

Ref: 3D-PJC38918